Trademarkia Logo

Canada

C$
Trademark Search in Canada
AKOUOS

View On IC.GC.CA

AKOUOS
SEARCHED

on 7 Nov 2024

Last Applicant/ Owned by

Akouos, Inc.

645 Summer StreetSuite 200Boston, MA 02210

US

Serial Number

2106297 filed on 12th May 2021

Correspondent Address

BORDEN LADNER GERVAIS LLP

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

CA

K1P1J9

AKOUOS

Trademark usage description

drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; biologics and small molecules in the nature Read More

Classification Information

Class [005]
Gene therapy products to restore, improve, and preserve hearing; gene therapy products to treat inner ear disorders and conditions; viral vectors, non-viral vectors, gene therapy vectors all for medical purposes in gene therapy for inner ear disorders and conditions; biotechnological platform technology, namely, biological nanoparticles and adenoviruses for gene delivery to biological cells that includes adeno-associated viral (AAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to restore, improve and preserve hearing; biotechnological platform technology, namely, biological nanoparticles and adenoviruses for gene delivery to biological cells that includes adeno-associated viral (AAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to treat inner ear disorders and conditions

Classification kind code

11

Class [010]
Viral vector delivery platforms for gene therapy

Classification kind code

11

Class [042]
Scientific research consulting in the field of inner ear disorders and conditions and hearing loss; custom development of biochemical reagents and biological nanoparticles, namely, therapeutic compositions that include adeno-associated viral (AAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to restore, improve and preserve hearing; custom development of biochemical reagents and biological nanoparticles, namely, therapeutic compositions that include adeno-associated viral (AAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to treat inner ear disorders and conditions

Classification kind code

11

Class [044]
Providing a website featuring education information regarding inner ear disorders and conditions, hearing loss and genetics

Classification kind code

11

Mark Details

Serial Number

2106297

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 22
on 7th Nov 2024		Search Recorded
Submitted for opposition 20
on 7th Nov 2024		Examiner's First Report
Submitted for opposition 48
on 13th Oct 2023		Agent Changed
Submitted for opposition 287
on 4th May 2022		Pre-Assessment Letter Sent
Submitted for opposition 30
on 12th May 2021		Filed
Submitted for opposition 1
on 12th May 2021		Created
Submitted for opposition 31
on 12th May 2021		Formalized